Immunotherapy administered before and after chemotherapy along with surgical removal of the bladder improved survival compared to chemotherapy alone in patients with muscle-invasive bladder cancer, according to a recent study published in the New England Journal of Medicine.
Feinberg students, staff, trainees and faculty gathered to celebrate scientific discovery and presented research posters and abstracts at Feinberg’s 18th annual Lewis Landsberg Research Day on Thursday, Sept. 12.
Patients who live in rural communities, Hispanic patients and Black patients with pre-existing diabetic retinopathy are less likely to receive annual diabetic eye exams than white patients, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists have conducted the largest lifestyle-intervention trial for U.S. South Asians, helping build a larger body of research to better represent the diverse and vastly underrepresented group.
Northwestern Medicine investigators have shed new light on how white blood cells in the retina function during inflammation and possibly during retinal vascular diseases with inflammatory components like diabetic retinopathy, according to a study recently published in the Journal of Clinical Investigation.
A recent publication has outlined the novel and practical approach to improving transplant equity pioneered by Northwestern’s African American Transplant Access Program.
Investigators have demonstrated how molecular profiling of tumors can be used to help predict treatment response and survival in patients with meningiomas, the most common type of primary brain tumor, according to a recent study published in Nature Medicine.
Northwestern Medicine scientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system, according to recent findings.
A combination therapy improved progression-free survival in patients with metastatic castration-resistant prostate cancer with genetic mutations compared to either therapy alone or sequentially, according to results from a Northwestern Medicine-led clinical trial.
Northwestern Medicine investigators have identified distinct T-cell responses associated with patient outcomes in unvaccinated individuals with severe SARS-CoV-2 pneumonia, according to findings published in Nature Immunology.
